GLP-1 News by Pen Hub

Support may be needed for up to a year after stopping weight loss jabs, according to new expert guidance.

Real-world side effects of GLP-1 meds, as told on Facebook, now backed by science.

GLP-1s may do more than curb appetite; a new study suggests they could help ease asthma, too.

U.S. regulators just updated GLP-1 warnings, including Ozempic and Mounjaro. Here’s what they added.

Could a cheaper GLP-1 be just around the corner? Big pharma’s making moves, and the UK might feel the ripple.

Could weight-loss jabs protect your brain? A study links Ozempic and Mounjaro to lower risks of dementia, stroke, and death.

UK regulators are probing links between GLP-1 weight loss jabs and rare cases of pancreatitis.

From today, GPs in England can prescribe Mounjaro on the NHS. Here's who qualifies, and what it means for you.

Wondering if you qualify? NHS access is more limited than you think. Here’s how it really works.